Global health trials scheme
We are pleased to jointly announce the launch of the sixth call for proposals under this initiative.
The Wellcome Trust, the UK Medical Research Council (MRC) and the UK Department for International Development are committed to strengthening the evidence base for improving health in low- and middle-income countries. Together we are investing a total of £20 million for the sixth call of this initiative to fund late-stage trials of interventions that will help improve health in these countries, by addressing the major causes of mortality and morbidity.
The scheme is primarily focused on late-stage (equivalent to phase III/IV) clinical and health intervention trials evaluating efficacy and effectiveness.
However, we may consider Phase IIb trials of major relevance to the objectives of the call. If you are considering submitting a Phase IIb stage trial, please consult one of the partner agencies involved for further guidance.
The scheme is aimed at funding Randomised Controlled Trials (RCTs), although other types of methodologies may be used alongside the RCT to explore implementation and operational issues.
The scope of the scheme includes, but is not limited to, behavioural interventions, complex interventions, disease management, drugs, vaccines, and hygiene and diagnostic strategies.
The scheme is open to the best proposals addressing any major health related problem affecting low- and middle-income countries that are likely to produce implementable results, particularly those that affect the most vulnerable populations.
Funding for preliminary studies
In addition to full applications in this call we will also be offering a second application type: trial development grants.
The scheme remains primarily a mechanism to support full trials. However, we recognise that preliminary work is often needed in order for applicants to develop innovative partnerships and trial proposals.
The aims of a trial development grant must be to address questions which need to be answered before a credible, competitive, full trial can be designed.
You can read more about this scheme on the MRC website.
A total of up to £20 million pounds is available. Depending on the range of proposals received, around £1.5 million of this amount is expected to be spent on trial development grants, and this amount is also expected fund several awards.
Support may be requested for:
- all research costs that are attributable to the trial
- the cost of hosting trial steering and data monitoring committees
- training and support for a trial manager.
The MRC website has more information about the support on offer.
Trials should be based in low- or middle-income countries. Academic groups based either in the countries where the studies will take place or based in the UK are eligible to apply.
Please refer to the MRC website for more information on the eligibility criteria.
Applications should be submitted to and will be processed by the MRC on behalf of the three partner agencies.
There are two application types:
1. Outline proposals for a global health trial research grant (two-stage application process)
2. Trial development grant proposals (one-stage application process).
Please see the Guidance document on the MRC website for further information on applying through either route.
The MRC must receive your outline proposal by 16:00 British Summer Time (BST) on Thursday 10 September 2015.
For more information on the key issues your proposal should address, details of the funding on offer and application and eligibility criteria, visit the Medical Research Council website or email email@example.com.
This is an annual competition.
- Outline application deadline: 16:00 BST Thursday 10 September 2015
- Full application deadline: February 2016
- Decisions: 16-17 May 2016.
Please email any questions to Mandy Brown at the MRC.
To discuss your proposal informally, email Bibi Oni at the Wellcome Trust.
Trials funded by the Joint Global Health Trials Initiative
Professor Diana Gibb, Medical Research Council
A randomised trial of therapy shortening for minimal tuberculosis with new WHO-recommended doses and FDC drugs in African/Indian HIV+/HIV- children
Professor Mark W Rowland, London School of Hygiene and Tropical Medicine
Combination interventions for controlling malaria transmitted by pyrethroid resistant mosquitoes: a novel bed net with synergist and IRS formulation
Dr Hector Garcia, Universidad Peruana Cayetano Heredia, Peru
Pilot Study - a case for free supply of anti-epileptic drugs in resource-poor regions
Professor Kathryn Maitland, Imperial College London
MICA: children's oxygen administration strategies trial
Dr Patrick Phillips, MRC Clinical Trials Unit at University College London
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis: the ‘TRUNCATE-TB’ trial
Dr Immo Kleinschmidt, London School of Hygiene and Tropical Medicine
From malaria control to sustainable elimination: cluster randomised trial comparing targeted versus generalised vector control in South Africa
Dr Karen M Devries, London School of Hygiene and Tropical Medicine
The Good Schools Study: a cluster randomised controlled trial of an intervention to prevent violence against children in Ugandan primary schools
Dr Anatoli Kamali, MRC/UVRI Uganda Research Unit on AIDS, Uganda
Pilot Study - uptake and impact of HIV combination (HIVCOMB) interventions on HIV incidence among fishing communities in Uganda
Dr Anita Zaidi, Aga Khan University, Pakistan
A double blind randomised community-based trial of amoxicillin versus placebo for non-severe pneumonia in children aged 2-59 months in Pakistan
Professor Tazeen Jafar, Aga Khan University, Pakistan and National University of Singapore, Singapore
Pilot Study - integrated primary care strategies to reduce high blood pressure: a cluster randomised trial in rural Pakistan and Sri Lanka
Professor Richard Price, University of Oxford
Improving the radical cure of vivax malaria: a multicentre randomised comparison of short and long course primaquine regimens
Dr Audrey Prost,University College London
Community intervention to improve growth among children under two in rural India
Mr Arri Coomarasamy, University of Birmingham
Effectiveness of antibiotic prophylaxis during surgical evacuation of the uterus for miscarriage management in low-income countries (AMS trial)
Professor Umberto D'Alessandro, MRC Unit, The Gambia
Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine
Dr Gail Davey, University of Sussex
Randomised controlled trial of podoconiosis treatment in northern Ethiopia
Dr Carlton Evans, Imperial College London
Community randomised evaluation of socioeconomic intervention to prevent TB
Professor Graham Foster, Queen Mary, University of London
Step-down affordable treatment for chronic hepatitis B infection in Africa and India Acronym - STEP-HEP
Professor Stephen Gordon, Liverpool School of Tropical Medicine
An advanced cookstove intervention to prevent pneumonia in children under five years old in Malawi: a cluster randomised controlled trial
Professor Oye Gureje, University of Ibadan, Nigeria
A cluster randomised controlled trial of a STEPped CARE intervention for depression in primary care
Dr Sarah Staedke, London School of Hygiene and Tropical Medicine
School-based treatment with ACT to reduce transmission; evaluation of the community impact of intermittent preventive treatment for malaria in Uganda
Dr Ambrose Talisuna, University of Oxford
Efficacy of mobile phone short message service (SMS) on malaria treatment adherence and post-treatment review
Professor Sir Brian Greenwood, London School of Hygiene and Tropical Medicine
A trial of the benefit of including azithromycin in the drug combination used for seasonal malaria chemoprevention in African children
Dr Somphou Sayasone, Swiss Tropical and Health Institute, Switzerland
Tribendimidine for the treatment of liver fluke infection in South-east Asia
Professor Diana Gibb, Medical Research Council
Reduction of Early mortaLITY in HIV-infected African adults and children starting antiretroviral therapy: REALITY trial
Dr Jeremy Day, University of Oxford Clinical Research Unit, Vietnam
A clinical trial of dexamethasone to reduce mortality in cryptococcal meningitis
Dr Badara Cisse, London School of Hygiene and Tropical Medicine
Randomised trial of spatially targeted control to virtually eliminate malaria in areas of very low incidence and patchy transmission in Senegal
Dr Penelope A Phillips-Howard, Liverpool John Moores University
The effectiveness of Mooncups to reduce school absenteeism, and sexual and reproductive harms in Kenyan schoolgirls
Dr Thuy Le, University of Oxford
A randomised, open-label, comparative study of Itraconazole vs Amphotericin B for the induction therapy of Penicilliosis
Dr Alison Grant, London School of Hygiene and Tropical Medicine
TB fast track: effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART
Professor Feiko ter Kuile, Liverpool School of Tropical Medicine
Intermittent screening and treatment or intermittent preventive therapy for control of malaria in pregnancy in Indonesia
Dr Mark Hatherill, University of Cape Town, South Africa
MVA85A Tuberculosis vaccine prime and selective delayed BCG boost in infants of HIV-infected mothers
Dr Andrew Weeks, University of Liverpool
Induction of labour in pre-eclamptic women: a randomised trial comparing balloon catheter with oral misoprostol